EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2026 (TTM): S$0.19

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is S$0.19. In 2024 the company made an earnings per share (EPS) of S$0.17 an increase over its 2023 EPS that were of S$0.12.

EPS history for Jiangsu Hengrui Medicine from 2000 to 2026

Annual EPS

Year	EPS	Change
2026 (TTM)	S$0.19
2024	S$0.17	42.43%
2023	S$0.12	8.77%
2022	S$0.11	-20.62%
2021	S$0.14	-26.59%
2020	S$0.19	27.24%
2019	S$0.15	28.41%
2018	S$0.12	20.04%
2017	S$0.09825	31.21%
2016	S$0.07488	11.46%
2015	S$0.06718	36.27%
2014	S$0.04930	19.77%
2013	S$0.04116	18.05%
2012	S$0.03487	23.9%
2011	S$0.02814	26.9%
2010	S$0.02218	12.37%
2009	S$0.01974	56.6%
2008	S$0.01260	9.18%
2007	S$0.01154	114.48%
2006	S$0.005382	64.83%
2005	S$0.003265	35.55%
2004	S$0.002409	29.73%
2003	S$0.001857	19.86%
2002	S$0.001549	-2.71%
2001	S$0.001592	1.02%
2000	S$0.001576

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions